Relapsed/Refractory Hairy Cell Leukemia

DrugDrug NameDrug Description
DB12688Moxetumomab pasudotoxA CD22-specific antibody conjugated to a truncated exotoxin used to treat relapsed or refractory hairy cell leukemia in patients who have already been treated with a purine nucleoside analog and one other treatment.
DrugDrug NamePhaseStatusCount
DB15699Brexucabtagene autoleucel2Recruiting1
DB00531Cyclophosphamide2Recruiting1
DB01073Fludarabine2Recruiting1
DB12688Moxetumomab pasudotoxNot AvailableApproved for Marketing1